Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Weekly dihydroartemisinin-piperaquine versus monthly sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cell anaemia in Uganda and Malawi (CHEMCHA): a randomised, double-blind, placebo-controlled trial.
Idro R, Nkosi-Gondwe T, Opoka R, Ssenkusu JM, Dennis K, Tsirizani L, Akun P, Rujumba J, Nambatya W, Kamya C, Phiri N, Joanita K, Komata R, Innussa M, Tenywa E, John CC, Tarning J, Denti P, Wasmann RE, Ter Kuile FO, Robberstad B, Phiri KS. Idro R, et al. Among authors: phiri ks. Lancet Infect Dis. 2024 Dec 20:S1473-3099(24)00737-0. doi: 10.1016/S1473-3099(24)00737-0. Online ahead of print. Lancet Infect Dis. 2024. PMID: 39718172 Free article.
Intermittent preventive therapy for malaria with monthly artemether-lumefantrine for the post-discharge management of severe anaemia in children aged 4-59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial.
Phiri K, Esan M, van Hensbroek MB, Khairallah C, Faragher B, ter Kuile FO. Phiri K, et al. Lancet Infect Dis. 2012 Mar;12(3):191-200. doi: 10.1016/S1473-3099(11)70320-6. Epub 2011 Dec 13. Lancet Infect Dis. 2012. PMID: 22172305 Clinical Trial.
Dihydroartemisinin-piperaquine or sulphadoxine-pyrimethamine for the chemoprevention of malaria in children with sickle cell anaemia in eastern and southern Africa (CHEMCHA): a protocol for a multi-centre, two-arm, double-blind, randomised, placebo-controlled superiority trial.
Nkosi-Gondwe T, Robberstad B, Opoka R, Kalibbala D, Rujumba J, Galileya LT, Akun P, Nambatya W, Ssenkusu J, TerKuile F, Phiri K, Idro R. Nkosi-Gondwe T, et al. Trials. 2023 Apr 5;24(1):257. doi: 10.1186/s13063-023-07274-4. Trials. 2023. PMID: 37016392 Free PMC article.
Malaria chemoprevention with monthly dihydroartemisinin-piperaquine for the post-discharge management of severe anaemia in children aged less than 5 years in Uganda and Kenya: study protocol for a multi-centre, two-arm, randomised, placebo-controlled, superiority trial.
Kwambai TK, Dhabangi A, Idro R, Opoka R, Kariuki S, Samuels AM, Desai M, van Hensbroek MB, John CC, Robberstad B, Wang D, Phiri K, Ter Kuile FO. Kwambai TK, et al. Trials. 2018 Nov 6;19(1):610. doi: 10.1186/s13063-018-2972-1. Trials. 2018. PMID: 30400934 Free PMC article.
Malaria Chemoprevention in the Postdischarge Management of Severe Anemia.
Kwambai TK, Dhabangi A, Idro R, Opoka R, Watson V, Kariuki S, Kuya NA, Onyango ED, Otieno K, Samuels AM, Desai MR, Boele van Hensbroek M, Wang D, John CC, Robberstad B, Phiri KS, Ter Kuile FO. Kwambai TK, et al. Among authors: phiri ks. N Engl J Med. 2020 Dec 3;383(23):2242-2254. doi: 10.1056/NEJMoa2002820. N Engl J Med. 2020. PMID: 33264546 Free PMC article. Clinical Trial.
Adherence to community versus facility-based delivery of monthly malaria chemoprevention with dihydroartemisinin-piperaquine for the post-discharge management of severe anemia in Malawian children: A cluster randomized trial.
Nkosi-Gondwe T, Robberstad B, Mukaka M, Idro R, Opoka RO, Banda S, Kühl MJ, O Ter Kuile F, Blomberg B, Phiri KS. Nkosi-Gondwe T, et al. Among authors: phiri ks. PLoS One. 2021 Sep 10;16(9):e0255769. doi: 10.1371/journal.pone.0255769. eCollection 2021. PLoS One. 2021. PMID: 34506503 Free PMC article. Clinical Trial.
Post-discharge morbidity and mortality in children admitted with severe anaemia and other health conditions in malaria-endemic settings in Africa: a systematic review and meta-analysis.
Kwambai TK, Mori AT, Nevitt S, van Eijk AM, Samuels AM, Robberstad B, Phiri KS, Ter Kuile FO. Kwambai TK, et al. Among authors: phiri ks. Lancet Child Adolesc Health. 2022 Jul;6(7):474-483. doi: 10.1016/S2352-4642(22)00074-8. Epub 2022 May 21. Lancet Child Adolesc Health. 2022. PMID: 35605629 Free PMC article.
Economic evaluation of postdischarge malaria chemoprevention in preschool children treated for severe anaemia in Malawi, Kenya, and Uganda: A cost-effectiveness analysis.
Kühl MJ, Gondwe T, Dhabangi A, Kwambai TK, Mori AT, Opoka R, John CC, Idro R, Ter Kuile FO, Phiri KS, Robberstad B. Kühl MJ, et al. Among authors: phiri ks. EClinicalMedicine. 2022 Oct 1;52:101669. doi: 10.1016/j.eclinm.2022.101669. eCollection 2022 Oct. EClinicalMedicine. 2022. PMID: 36313146 Free PMC article.
112 results